Concorde Financial Corp Abb Vie Inc. Transaction History

Concorde Financial Corp

$156 Million
Q2 2025

A detailed history of Concorde Financial Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Concorde Financial Corp holds 32,705 shares of ABBV stock, worth $7.74 Million. This represents 3.88% of its overall portfolio holdings.

Number of Shares

32,705

Previous 32,799 0.29%

Holding current value

$7.74 Million

Previous $6.87 Million 11.67%

% of portfolio

3.88%

Previous 4.05%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$170.16 - $206.27 $15,995 - $19,389	-94 Reduced 0.29%	32,705 $6.07 Million
Q1 2025 May 14, 2025	SELL	$169.2 - $216.66 $16,581 - $21,232	-98 Reduced 0.3%	32,799 $6.87 Million
Q4 2024 Feb 14, 2025	BUY	$164.99 - $203.87 $20,458 - $25,279	124 Added 0.38%	32,897 $5.85 Million
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $68,812 - $83,718	-420 Reduced 1.27%	32,773 $6.47 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $1.27 Million - $1.49 Million	-8,225 Reduced 19.86%	33,193 $5.69 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $11,187 - $12,747	-70 Reduced 0.17%	41,418 $7.54 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $4.79 Million - $5.39 Million	34,788 Added 519.22%	41,488 $6.43 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $4.55 Million - $5.26 Million	-34,038 Reduced 83.55%	6,700 $998,000
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $75,530 - $93,993	-570 Reduced 1.38%	40,738 $5.49 Million
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $84,018 - $96,759	-581 Reduced 1.39%	41,308 $6.58 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $10,871 - $12,468	-81 Reduced 0.19%	41,889 $5.62 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $493,367 - $627,231	-3,585 Reduced 7.87%	41,970 $6.43 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $169,198 - $209,927	-1,282 Reduced 2.74%	45,555 $6.78 Million
Q4 2021 Feb 17, 2022	BUY	$107.43 - $135.93 $5.03 Million - $6.37 Million	46,837 New	46,837 $6.33 Million

Others Institutions Holding ABBV

# of Institutions

4,293

Shares Held

1.3B

Call Options Held

16.1M

Put Options Held

10.9M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $418B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concorde Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Concorde Financial Corp with notifications on news.

Account

Concorde Financial Corp Abb Vie Inc. Transaction History